An overview of influenza viruses and vaccines

RF Nuwarda, AA Alharbi, V Kayser - Vaccines, 2021 - mdpi.com
Influenza remains one of the major public health concerns because it causes annual
epidemics and can potentially instigate a global pandemic. Numerous countermeasures …

Chitosan-based nanoparticles against viral infections

H Boroumand, F Badie, S Mazaheri… - Frontiers in Cellular …, 2021 - frontiersin.org
Viral infections, in addition to damaging host cells, can compromise the host immune
system, leading to frequent relapse or long-term persistence. Viruses have the capacity to …

Progress towards the development of a universal influenza vaccine

WC Wang, EE Sayedahmed, S Sambhara, SK Mittal - Viruses, 2022 - mdpi.com
Influenza viruses are responsible for millions of cases globally and significantly threaten
public health. Since pandemic and zoonotic influenza viruses have emerged in the last 20 …

Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs

S Dhakal, S Renu, S Ghimire… - Frontiers in …, 2018 - frontiersin.org
Annually, swine influenza A virus (SwIAV) causes severe economic loss to swine industry.
Currently used inactivated SwIAV vaccines administered by intramuscular injection provide …

Advances in nanomedicine for the treatment of infectious diseases caused by viruses

SR Dash, CN Kundu - Biomaterials Science, 2023 - pubs.rsc.org
Viruses have a worldwide impact on healthcare and social and economic growth because
they are the largest cause of mortality due to infectious diseases. Furthermore, the long-term …

[HTML][HTML] Development of multi-epitope peptide-based vaccines against SARS-CoV-2

HX Lim, J Lim, SD Jazayeri, S Poppema, CL Poh - Biomedical Journal, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic
involving so far more than 22 million infections and 776,157 deaths. Effective vaccines are …

Microencapsulation for pharmaceutical applications: a review

C Yan, SR Kim - ACS Applied Bio Materials, 2024 - ACS Publications
In order to improve bioavailability, stability, control release, and target delivery of active
pharmaceutical ingredients (APIs), as well as to mask their bitter taste, to increase their …

Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs

S Dhakal, J Hiremath, K Bondra… - Journal of Controlled …, 2017 - Elsevier
Swine influenza virus (SwIV) is one of the important zoonotic pathogens. Current flu
vaccines have failed to provide cross-protection against evolving viruses in the field. Poly …

Current and prospective control strategies of influenza A virus in swine

HA Salvesen, CBA Whitelaw - Porcine health management, 2021 - Springer
Abstract Background Influenza A Viruses (IAV) are endemic pathogens of significant
concern in humans and multiple keystone livestock species. Widespread morbidity in swine …

Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity

D Sanchez-Guzman, P Le Guen, B Villeret, N Sola… - Biomaterials, 2019 - Elsevier
Most of current influenza virus vaccines fail to develop a strong immunity at lung mucosae
(site of viral entry) due to sub-optimal vaccination protocols (eg inactivated virus …